Champions Oncology (CSBR) EPS (Basic) (2010 - 2026)
Champions Oncology (CSBR) recorded quarterly EPS (Basic) of -$0.02 in Q1 2026, down 200.0% quarter-over-quarter from $0.02 in Q4 2025, and down 106.06% on a YoY basis from $0.33 in Q1 2025.
Champions Oncology (CSBR) EPS (Basic) (2010 - 2026) Analysis & Trends
Champions Oncology's EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.02 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 106.06% year-over-year to -$0.02; the TTM figure through Jan 2026 stood at -$0.17 (down 136.17% YoY), while the FY2025 annual figure was $0.34, up 162.96% from the prior year.
- EPS (Basic) was -$0.02 for Q1 2026 at Champions Oncology, down from $0.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.33 in Q1 2025 to a low of -$0.19 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.03 across 5 years, with a median of -$0.02 in 2022.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) tumbled 12583.1% in 2023, then jumped 273.68% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.0 in 2022, then plunged by 12583.1% to -$0.15 in 2023, then jumped by 133.33% to $0.05 in 2024, then tumbled by 60.0% to $0.02 in 2025, then tumbled by 200.0% to -$0.02 in 2026.
- The last three EPS (Basic) figures came in at -$0.02 (Q1 2026), $0.02 (Q4 2025), and -$0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.06 |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -0.02 |
| Oct 31, 2025 | 0.02 |
| Jul 31, 2025 | -0.03 |
| Apr 30, 2025 | -0.14 |
| Jan 31, 2025 | 0.33 |
| Oct 31, 2024 | 0.05 |
| Jul 31, 2024 | 0.10 |
| Apr 30, 2024 | -0.01 |
| Jan 31, 2024 | -0.19 |
| Oct 31, 2023 | -0.15 |
| Jul 31, 2023 | -0.19 |
| Apr 30, 2023 | -0.19 |
| Jan 31, 2023 | -0.18 |
| Oct 31, 2022 | 0.00 |
| Jul 31, 2022 | -0.02 |
| Apr 30, 2022 | -0.03 |
| Jan 31, 2022 | 0.06 |
| Oct 31, 2021 | 0.02 |
| Jul 31, 2021 | -0.01 |
| Apr 30, 2021 | -0.05 |